ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628676 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628676; 2) Community: the network communities that were significantly associated with the response to NSC 628676; 3) Molecule: the relationships between components within communities and NSC 628676; 4) MDR: the compounds that were significantly associated with the NSC 628676.

NSC Compound Enrichment Correlation
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0303322639291198 0.69827257
NSC 665496 Null 0.0303322639291198 0.0064633985
NSC 667545 Null 0.0303322639291198 0.33261694
NSC 671170 Null 0.0303322639291198 0.1007385
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0303322639291198 0.35904724
NSC 681636 Camptothecin Derivative 0.0303322639291198 0.73325586
NSC 681645 Camptothecin Derivative 0.0303322639291198 0.75608528
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0303322639291198 0.44318313
NSC 688021 Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester 0.0303322639291198 0.67014227
NSC 691845 Null 0.0303322639291198 0.013476335
Total:66  Current:42    [First] [Prev] [Next] [Last]